Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.

Volume 8 (2011), Issue 9 (September)

1. Abnormal Glucocorticoid Receptor mRNA and Protein Isoform Expression in the Prefrontal Cortex in Psychiatric Illness.
   Neuropsychopharmacology. [Abstract] [Full-text]
2. The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder.
   J Affect Disord. [Abstract] [Full-text]
3. Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea.
   Ann Pharmacother, 45(9): e45. [Abstract] [Full-text]
4. Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice.
   J Clin Invest, 121(9): 3756-62. [Abstract] [Full-text]
5. Is cerebellar volume related to bipolar disorder?
   J Affect Disord. [Abstract] [Full-text]
6. Glycogen synthase kinase-3 in the etiology and treatment of mood disorders.
   Front Mol Neurosci, 4: 16. [Abstract] [Full-text]
7. Adequacy of treatment for patients with schizophrenia spectrum disorders and affective disorders in Lombardy, Italy.
   Psychiatr Serv, 62(9): 1079-84. [Abstract] [Full-text]
8. Direct costs of bipolar disorder versus other chronic conditions: an employer-based health plan analysis.
   Psychiatr Serv, 62(9): 1073-8. [Abstract] [Full-text]
9. Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorder.
   Psychiatr Serv, 62(9): 1032-40. [Abstract] [Full-text]
10. Ethnic disparities in antipsychotic drug use in British Columbia: a cross-sectional retrospective study.
    Psychiatr Serv, 62(9): 1026-31. [Abstract] [Full-text]
11. Functional genetic variation in the Rev-Erbα pathway and lithium response in the treatment of bipolar disorder.
    Genes Brain Behav. [Abstract] [Full-text]
12. "Folie circulaire" vs "Folie à double forme": contribution from a French national study.
    Eur Psychiatry, 26(6): 375-80. [Abstract] [Full-text]
13. From Genotype to Phenotype: Two Cases of Genetic Frontotemporal Lobar Degeneration with Premorbid Bipolar Disorder.
    J Alzheimers Dis. [Abstract] [Full-text]
14. Phenomenology of psychotic mood disorders: Lifetime and major depressive episode features.
    J Affect Disord. [Abstract] [Full-text]
15. Clinical usefulness of second-generation antipsychotics in treating children and adolescents diagnosed with bipolar or schizophrenic disorders.
    Paediatr Drugs, 13(5): 291-302. [Abstract] [Full-text]
16. Clinical usefulness of second-generation antipsychotics in treating children and adolescents diagnosed with bipolar or schizophrenic disorders.
    Paediatr Drugs, 13(5): 291-302. [Abstract] [Full-text]
17. A non-invasive method to isolate the neuronal linage from the nasal epithelium from schizophrenic and bipolar diseases.
    J Neurosci Methods, 201(1): 35-45. [Abstract] [Full-text]
18. A non-invasive method to isolate the neuronal linage from the nasal epithelium from schizophrenic and bipolar diseases.
    J Neurosci Methods, 201(1): 35-45. [Abstract] [Full-text]
19. Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder.
    Hum Psychopharmacol. [Abstract] [Full-text]
20. Combinations of SNPs related to signal transduction in bipolar disorder.
    PLoS One, 6(8): e23812. [Abstract] [Full-text]
21. A comparative study of reliability of self report of tobacco use among patients with bipolar and somatoform disorders.
    J Pharmacol Pharmacother, 2(3): 174-8. [Abstract] [Full-text]
22. Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury.
    J Neurotrauma. [Abstract] [Full-text]
23. Daily stress and cortisol patterns in parents of adult children with a serious mental illness.
    Health Psychol. [Abstract] [Full-text]
24. Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.
    Expert Opin Pharmacother, 12(14): 2245-63. [Abstract] [Full-text]
25. Mood stability versus mood instability in bipolar disorder: a possible role for emotional mental imagery.
    Behav Res Ther, 49(10): 707-13. [Abstract] [Full-text]
26. What we know and what we don't know about the treatment of schizoaffective disorder.
    Eur Neuropsychopharmacol, 21(9): 680-90. [Abstract] [Full-text]
27. Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder.
    Expert Opin Pharmacother, 12(14): 2245-63. [Abstract] [Full-text]
28. Mood stability versus mood instability in bipolar disorder: a possible role for emotional mental imagery.
    Behav Res Ther, 49(10): 707-13. [Abstract] [Full-text]
29. Clinical and cognitive correlates of suicide attempts in bipolar disorder: is suicide predictable?
    J Clin Psychiatry, 72(8): 1027-33. [Abstract] [Full-text]
30. Two-year diagnostic stability in early-onset first-episode psychosis.
    J Child Psychol Psychiatry, 52(10): 1089-98. [Abstract] [Full-text]
31. Acupuncture for the treatment of major depressive disorder: a randomized controlled trial.
    J Clin Psychiatry, 72(8): 1129-35. [Abstract] [Full-text]
32. Genetics of schizophrenia: new findings and challenges.
    Annu Rev Genomics Hum Genet, 12: 121-44. [Abstract] [Full-text]
33. 'It's something that I manage but it is not who I am': reflections on internalized stigma in individuals with bipolar disorder.
    Chronic Illn, 7(3): 209-24. [Abstract] [Full-text]
34. Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics.
    J Clin Psychiatry, 72(8): 1063-71. [Abstract] [Full-text]
35. Two-year diagnostic stability in early-onset first-episode psychosis.
    J Child Psychol Psychiatry, 52(10): 1089-98. [Abstract] [Full-text]
36. Bipolar disorder is common in depressed primary care patients.
    Postgrad Med, 123(5): 129-33. [Abstract] [Full-text]
37. Genetic structure of personality factors and bipolar disorder in families segregating bipolar disorder.
    J Affect Disord. [Abstract] [Full-text]
38. Prevalence of mood disorders and service use among US mothers by race and ethnicity: results from the National Survey of American Life.
    J Clin Psychiatry. [Abstract] [Full-text]
39. Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression.
    J Clin Psychiatry. [Abstract] [Full-text]
40. First-onset psychosis occurring in the postpartum period: a prospective cohort study.
    J Clin Psychiatry. [Abstract] [Full-text]
41. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder.
    J Affect Disord, 134(1): 138-44. [Abstract] [Full-text]
42. Treatment-induced manic switch in the course of unipolar depression can predict bipolarity: cluster analysis based evidence.
    J Affect Disord, 134(1): 91-101. [Abstract] [Full-text]
43. The impact of brief depressive episodes on the outcome of bipolar disorder and major depressive disorder: a 1-year prospective study.
    J Affect Disord, 134(1): 133-7. [Abstract] [Full-text]
44. Impulsivity, aggression and suicidal behavior in unipolar and bipolar disorders.
    J Affect Disord, 134(1): 112-8. [Abstract] [Full-text]
45. No association between affective and behavioral dysregulation and parameters of thyroid function in youths.
    J Affect Disord, 134(1): 478-82. [Abstract] [Full-text]
46. Mindfulness, response styles and dysfunctional attitudes in bipolar disorder.
    J Affect Disord, 134(1): 126-32. [Abstract] [Full-text]
47. A predictive model for diagnosing bipolar disorder based on the clinical characteristics of major depressive episodes in Chinese population.
    J Affect Disord, 134(1): 119-25. [Abstract] [Full-text]
48. Sleep matters: sleep functioning and course of illness in bipolar disorder.
    J Affect Disord, 134(1): 416-20. [Abstract] [Full-text]
49. Extreme positive and negative appraisals of activated states interact to discriminate bipolar disorder from unipolar depression and non-clinical controls.
    J Affect Disord, 134(1): 438-43. [Abstract] [Full-text]
50. Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor.
    J Affect Disord, 134(1): 427-30. [Abstract] [Full-text]
51. Timing, quantity and quality of stressful life events in childhood and preceding the first episode of bipolar disorder.
    J Affect Disord, 134(1): 434-7. [Abstract] [Full-text]
52. Comorbidity of delusional disorder with bipolar disorder: report of four cases.
    J Affect Disord, 134(1): 431-3. [Abstract] [Full-text]
53. Reactivity of affect and self-esteem during remission in bipolar affective disorder: an experimental investigation.
    J Affect Disord, 134(1): 102-11. [Abstract] [Full-text]
54. Antidepressant-associated mania or hypomania: a comparison with personality and bipolarity features of bipolar I disorder.
    J Affect Disord, 134(1): 85-90. [Abstract] [Full-text]
55. Mapping corpus callosum morphology in twin pairs discordant for bipolar disorder.
    Cereb Cortex, 21(10): 2415-24. [Abstract] [Full-text]
56. Glucocorticoid receptor polymorphism is associated with major depression and predominance of depression in the course of bipolar disorder.
    J Affect Disord, 134(1): 138-44. [Abstract] [Full-text]
57. Treatment-induced manic switch in the course of unipolar depression can predict bipolarity: cluster analysis based evidence.
    J Affect Disord, 134(1): 91-101. [Abstract] [Full-text]
58. The impact of brief depressive episodes on the outcome of bipolar disorder and major depressive disorder: a 1-year prospective study.
    J Affect Disord, 134(1): 133-7. [Abstract] [Full-text]
59. The incidence and prevalence of admissions for melancholia in two cohorts (1875-1924 and 1995-2005).
    J Affect Disord, 134(1): 45-51. [Abstract] [Full-text]
60. Impulsivity, aggression and suicidal behavior in unipolar and bipolar disorders.
    J Affect Disord, 134(1): 112-8. [Abstract] [Full-text]
61. No association between affective and behavioral dysregulation and parameters of thyroid function in youths.
    J Affect Disord, 134(1): 478-82. [Abstract] [Full-text]
62. Mindfulness, response styles and dysfunctional attitudes in bipolar disorder.
    J Affect Disord, 134(1): 126-32. [Abstract] [Full-text]
63. A predictive model for diagnosing bipolar disorder based on the clinical characteristics of major depressive episodes in Chinese population.
    J Affect Disord, 134(1): 119-25. [Abstract] [Full-text]
64. Sleep matters: sleep functioning and course of illness in bipolar disorder.
    J Affect Disord, 134(1): 416-20. [Abstract] [Full-text]
65. Extreme positive and negative appraisals of activated states interact to discriminate bipolar disorder from unipolar depression and non-clinical controls.
    J Affect Disord, 134(1): 438-43. [Abstract] [Full-text]
66. Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor.
    J Affect Disord, 134(1): 427-30. [Abstract] [Full-text]
67. Timing, quantity and quality of stressful life events in childhood and preceding the first episode of bipolar disorder.
    J Affect Disord, 134(1): 434-7. [Abstract] [Full-text]
68. Comorbidity of delusional disorder with bipolar disorder: report of four cases.
    J Affect Disord, 134(1): 431-3. [Abstract] [Full-text]
69. Reactivity of affect and self-esteem during remission in bipolar affective disorder: an experimental investigation.
    J Affect Disord, 134(1): 102-11. [Abstract] [Full-text]
70. Antidepressant-associated mania or hypomania: a comparison with personality and bipolarity features of bipolar I disorder.
    J Affect Disord, 134(1): 85-90. [Abstract] [Full-text]
71. Mapping corpus callosum morphology in twin pairs discordant for bipolar disorder.
    Cereb Cortex, 21(10): 2415-24. [Abstract] [Full-text]
72. Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania--a systematic review and meta-analysis.
    J Affect Disord, 134(1): 14-9. [Abstract] [Full-text]
73. A systematic review of the global distribution and availability of prevalence data for bipolar disorder.
    J Affect Disord, 134(1): 1-13. [Abstract] [Full-text]
74. Chronotherapeutics and psychiatry: setting the clock to relieve the symptoms.
    World J Biol Psychiatry, 12: 40-3. [Abstract] [Full-text]
75. Empirically derived subgroups of bipolar I patients with different comorbidity patterns of anxiety and substance use disorders in Han Chinese population.
    J Affect Disord. [Abstract] [Full-text]
76. The role of white matter damage in late onset bipolar disorder.
    Maturitas, 70(2): 160-3. [Abstract] [Full-text]
77. Signs and symptoms of acute mania: a factor analysis.
    BMC Psychiatry, 11: 137. [Abstract] [Full-text]
78. Collaborative care for patients with bipolar disorder: a randomised controlled trial.
    BMC Psychiatry, 11: 133. [Abstract] [Full-text]
79. Severe mood dysregulation: in the "light" of circadian functioning.
    Med Hypotheses, 77(4): 692-5. [Abstract] [Full-text]
80. The role of white matter damage in late onset bipolar disorder.
    Maturitas, 70(2): 160-3. [Abstract] [Full-text]
81. Severe mood dysregulation: in the "light" of circadian functioning.
    Med Hypotheses, 77(4): 692-5. [Abstract] [Full-text]
82. Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals.
    PLoS One, 6(8): e24185. [Abstract] [Full-text]
83. Cytogenetic effects of valproic acid and ziprasidone in human lymphocyte cultures.
    Neuropsychobiology, 64(4): 219-23. [Abstract] [Full-text]
84. Asenapine effects on cognitive and monoamine dysfunction elicited by subchronic phencyclidine administration.
    Neuropharmacology. [Abstract] [Full-text]
85. Competence to Consent to Sexual Activity in Bipolar Disorder and Schizophrenic Spectrum Disorders.
    Arch Sex Behav. [Abstract] [Full-text]
86. A network-based approach to prioritize results from genome-wide association studies.
    PLoS One, 6(9): e24220. [Abstract] [Full-text]
87. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders.
    PLoS One, 6(9): e23356. [Abstract] [Full-text]
88. Branch retinal vein occlusion associated with quetiapine fumarate.
    BMC Ophthalmol, 11: 24. [Abstract] [Full-text]
89. The Relationship Between Bipolar Disorder, Seasonality, and Premenstrual Symptoms.
    Curr Psychiatry Rep. [Abstract] [Full-text]
90. Screening for bipolar disorder with the Mood Disorders Questionnaire: a review.
    Harv Rev Psychiatry, 19(5): 219-28. [Abstract] [Full-text]
91. DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders.
    Neuropsychopharmacology, 36(11): 2318-27. [Abstract] [Full-text]
92. Cognitive regulation of emotion in bipolar I disorder and unaffected biological relatives.
    Acta Psychiatr Scand, 124(4): 307-16. [Abstract] [Full-text]
93. Endocannabinoid system dysfunction in mood and related disorders.
    Acta Psychiatr Scand, 124(4): 250-61. [Abstract] [Full-text]
94. DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders.
    Neuropsychopharmacology, 36(11): 2318-27. [Abstract] [Full-text]
95. Cognitive regulation of emotion in bipolar I disorder and unaffected biological relatives.
    Acta Psychiatr Scand, 124(4): 307-16. [Abstract] [Full-text]
96. Differentially expressed genes in major depression reside on the periphery of resilient gene coexpression networks.
    Front Neurosci, 5: 95. [Abstract] [Full-text]
97. Tapering antidepressants: Is 3 months slow enough?
    Med Hypotheses. [Abstract] [Full-text]
98. Synapsin III: Role in neuronal plasticity and disease.
    Semin Cell Dev Biol, 22(4): 416-24. [Abstract] [Full-text]
99. Association study of the KCNJ3 gene as a susceptibility candidate for schizophrenia in the Chinese population.
    Hum Genet. [Abstract] [Full-text]
100. DARPP-32, Jack of All Trades… Master of Which?
     Front Behav Neurosci, 5: 56. [Abstract] [Full-text]
101. Expression of the AMPA Receptor Subunits GluR1 and GluR2 is Associated with Granule Cell Maturation in the Dentate Gyrus.
     Front Neurosci, 5: 100. [Abstract] [Full-text]
102. Antipsychotic polypharmacy among patients admitted to a geriatric psychiatry unit.
     J Psychiatr Pract, 17(5): 368-74. [Abstract] [Full-text]
103. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.
     J Affect Disord. [Abstract] [Full-text]
104. Genuine clinical predictors of bipolar II disorder: An exploration of temporal and contextual characteristics.
     J Affect Disord. [Abstract] [Full-text]
105. The management of bipolar disorder in the perinatal period and risk factors for postpartum relapse.
     Eur Psychiatry. [Abstract] [Full-text]
106. Factors associated with the prescribing of olanzapine, quetiapine, and risperidone in patients with bipolar and related affective disorders.
     Pharmacotherapy, 31(8): 806-12. [Abstract] [Full-text]
107. Adverse Drug Events Related to Ziprasidone: A Meta-analysis of Randomized, Placebo-Controlled Trials.
     Pharmacotherapy, 31(9): 840-9. [Abstract] [Full-text]
108. Neurocognitive performance in children and adolescents with bipolar disorder: a review.
     Eur Child Adolesc Psychiatry, 20(9): 433-50. [Abstract] [Full-text]
109. Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy.
     J Psychopharmacol. [Abstract] [Full-text]
110. Genetics of circadian rhythms and mood spectrum disorders.
     Eur Neuropsychopharmacol, 21: S676-82. [Abstract] [Full-text]
111. Circadian rhythms and mood regulation: Insights from pre-clinical models.
     Eur Neuropsychopharmacol, 21: S683-93. [Abstract] [Full-text]
112. Prediction of long-term metabolic effects of olanzapine and risperidone treatment from baseline body mass index in schizophrenia and bipolar disorder.
     Psychiatry Res, 189(2): 200-7. [Abstract] [Full-text]
113. Bizarreness in dream reports and waking fantasies of psychotic schizophrenic and manic patients: empirical evidences and theoretical consequences.
     Psychiatry Res, 189(2): 195-9. [Abstract] [Full-text]
114. Prediction of long-term metabolic effects of olanzapine and risperidone treatment from baseline body mass index in schizophrenia and bipolar disorder.
     Psychiatry Res, 189(2): 200-7. [Abstract] [Full-text]
115. Bizarreness in dream reports and waking fantasies of psychotic schizophrenic and manic patients: empirical evidences and theoretical consequences.
     Psychiatry Res, 189(2): 195-9. [Abstract] [Full-text]
116. Retrospective chart review of a referenced EEG database in assisting medication selection for treatment of depression in patients with eating disorders.
     Neuropsychiatr Dis Treat, 7: 529-41. [Abstract] [Full-text]
117. BDNF function as a potential mediator of bipolar disorder and post-traumatic stress disorder comorbidity.
     Mol Psychiatry. [Abstract] [Full-text]
118. Screening for understanding of research in the inpatient psychiatry setting.
     J Empir Res Hum Res Ethics, 6(3): 65-72. [Abstract] [Full-text]
119. Preventing repetition of attempted suicide-II. The Amager Project, a randomized controlled trial.
     Nord J Psychiatry, 65(5): 292-8. [Abstract] [Full-text]
120. Preventing repetition of attempted suicide--II. The Amager project, a randomized controlled trial.
     Nord J Psychiatry, 65(5): 292-8. [Abstract] [Full-text]
121. A New Anti-Depressive Strategy for the Elderly: Ablation of FKBP5/FKBP51.
     PLoS One, 6(9): e24840. [Abstract] [Full-text]
122. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder.
     PLoS One, 6(9): e24597. [Abstract] [Full-text]
123. Impact of Depressive Symptoms on Future Alcohol Use in Patients with Co-Occurring Bipolar Disorder and Alcohol Dependence: A Prospective Analysis in an 8-Week Randomized Controlled Trial of Acamprosate.
     Alcohol Clin Exp Res. [Abstract] [Full-text]
124. Association between prior alcohol use disorders and decreased prefrontal gray matter volumes in bipolar I disorder patients.
     Neurosci Lett, 503(2): 136-40. [Abstract] [Full-text]
125. Association between prior alcohol use disorders and decreased prefrontal gray matter volumes in bipolar I disorder patients.
     Neurosci Lett, 503(2): 136-40. [Abstract] [Full-text]
126. Depressive symptoms in first episode schizophrenia spectrum disorder.
     Schizophr Res. [Abstract] [Full-text]
127. Identification of a blood-based biological signature in subjects with psychiatric disorders prior to clinical manifestation.
     World J Biol Psychiatry. [Abstract] [Full-text]
128. Maintenance Treatment Study Designs in Bipolar Disorder: Do They Demonstrate that Atypical Neuroleptics (Antipsychotics) are Mood Stabilizers?
     CNS Drugs, 25(10): 819-27. [Abstract] [Full-text]
129. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?
     J Neuroinflammation, 8: 94. [Abstract] [Full-text]
130. Polymorphisms in melatonin synthesis pathways: possible influences on depression.
     J Circadian Rhythms, 9: 8. [Abstract] [Full-text]
131. Valproic Acid Induces Monoamine Oxidase A via Akt/Forkhead Box O1 Activation.
     Mol Pharmacol, 80(4): 714-23. [Abstract] [Full-text]
132. Maintenance treatment study designs in bipolar disorder: do they demonstrate that atypical neuroleptics (antipsychotics) are mood stabilizers?
     CNS Drugs, 25(10): 819-27. [Abstract] [Full-text]
133. Valproic acid induces monoamine oxidase A via Akt/forkhead box O1 activation.
     Mol Pharmacol, 80(4): 714-23. [Abstract] [Full-text]
134. Second generation antipsychotics in the treatment of bipolar depression: a systematic review and meta-analysis.
     J Psychopharmacol. [Abstract] [Full-text]
135. Epidemiology of major depression with atypical features: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).
     J Clin Psychiatry. [Abstract] [Full-text]
136. Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression.
     J Clin Psychiatry. [Abstract] [Full-text]
137. Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex.
     Int J Neuropsychopharmacol. [Abstract] [Full-text]
138. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder.
     Hum Mol Genet. [Abstract] [Full-text]
139. The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function.
     Mol Psychiatry, 16(10): 1006-23. [Abstract] [Full-text]
140. Therapeutic options in treatment-resistant depression.
     Ann Med, 43(7): 512-30. [Abstract] [Full-text]
141. The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function.
     Mol Psychiatry, 16(10): 1006-23. [Abstract] [Full-text]
142. An observational nationwide register based cohort study on lamotrigine versus lithium in bipolar disorder.
     J Psychopharmacol. [Abstract] [Full-text]
143. Granulomatous interstitial nephritis associated with atypical drug-induced hypersensitivity syndrome induced by carbamazepine.
     Clin Exp Nephrol. [Abstract] [Full-text]
144. Lithium, but not valproic acid or carbamazepine, suppresses impulsive-like action in rats.
     Psychopharmacology (Berl). [Abstract] [Full-text]
145. Episode cycles with increasing recurrences in first-episode bipolar-I disorder patients.
     J Affect Disord. [Abstract] [Full-text]
146. Portability of a screener for pediatric bipolar disorder to a diverse setting.
     Psychol Assess. [Abstract] [Full-text]
147. Better understanding of mechanisms of schizophrenia and bipolar disorder: From human gene expression profiles to mouse models.
     Neurobiol Dis. [Abstract] [Full-text]
148. Self-report reasons for alcohol use in bipolar disorders: why drink despite the potential risks?
     Clin Psychol Psychother, 18(5): 418-25. [Abstract] [Full-text]
149. Behavioural risk of bipolar disorder in an analogue population: the role of cognitive, developmental and interpersonal factors.
     Clin Psychol Psychother, 18(5): 411-7. [Abstract] [Full-text]
150. A comparison of mood-dependent memory in bipolar disorder and normal controls.
     Clin Psychol Psychother, 18(5): 379-86. [Abstract] [Full-text]
151. A review and synthesis of positive emotion and reward disturbance in bipolar disorder.
     Clin Psychol Psychother, 18(5): 356-65. [Abstract] [Full-text]
152. Comparative Effectiveness in Pain-Related Outcomes and Health Care Utilizations between Veterans with Major Depressive Disorder Treated with Duloxetine and Other Antidepressants: A Retrospective Propensity Score-Matched Comparison.
     Pain Pract. [Abstract] [Full-text]
153. Diagnostic consistency of major depression with psychosis across 10 years.
     J Clin Psychiatry, 72(9): 1207-13. [Abstract] [Full-text]
154. Integrated motivational interviewing and cognitive-behavioural therapy for bipolar disorder with comorbid substance use.
     Clin Psychol Psychother, 18(5): 426-37. [Abstract] [Full-text]
155. Hypomanic personality, stability of self-esteem and response styles to negative mood.
     Clin Psychol Psychother, 18(5): 397-410. [Abstract] [Full-text]
156. What basic emotions are experienced in bipolar disorder?
     Clin Psychol Psychother, 18(5): 366-78. [Abstract] [Full-text]
157. Structure and evolutionary history of DISC1.
     Hum Mol Genet, 20: R175-81. [Abstract] [Full-text]
158. Meta-analysis of epidemiologic studies of pediatric bipolar disorder.
     J Clin Psychiatry, 72(9): 1250-6. [Abstract] [Full-text]
159. Sensitivity to stress among the offspring of parents with bipolar disorder: a study of daytime cortisol levels.
     Psychol Med, 41(11): 2447-57. [Abstract] [Full-text]
160. Clinical utility of early improvement to predict response or remission in acute mania: focus on olanzapine and risperidone.
     J Clin Psychiatry, 72(9): 1236-41. [Abstract] [Full-text]
161. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.
     Br J Pharmacol, 164(4): 1301-21. [Abstract] [Full-text]
162. Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.
     J Clin Psychiatry, 72(9): 1214-21. [Abstract] [Full-text]
163. Downregulation and upregulation of glial connexins may cause synaptic imbalances responsible for the pathophysiology of bipolar disorder.
     CNS Neurosci Ther, 17(5): 281-93. [Abstract] [Full-text]
164. Psychotherapy for bipolar disorder: a review of the most recent studies.
     Curr Opin Psychiatry, 24(6): 549-55. [Abstract] [Full-text]
165. Current pharmacological approaches and perspectives in the treatment of geriatric mood disorders.
     Curr Opin Psychiatry, 24(6): 473-7. [Abstract] [Full-text]
166. Structure and evolutionary history of DISC1.
     Hum Mol Genet, 20: R175-81. [Abstract] [Full-text]
167. Sensitivity to stress among the offspring of parents with bipolar disorder: a study of daytime cortisol levels.
     Psychol Med, 41(11): 2447-57. [Abstract] [Full-text]
168. The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders.
     Br J Pharmacol, 164(4): 1301-21. [Abstract] [Full-text]
169. Predictive animal models of mania: hits, misses and future directions.
     Br J Pharmacol, 164(4): 1263-84. [Abstract] [Full-text]
170. Downregulation and upregulation of glial connexins may cause synaptic imbalances responsible for the pathophysiology of bipolar disorder.
     CNS Neurosci Ther, 17(5): 281-93. [Abstract] [Full-text]
171. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.
     Res Social Adm Pharm. [Abstract] [Full-text]
172. Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.
     J Med Econ. [Abstract] [Full-text]
173. Genome-wide association study identifies five new schizophrenia loci.
     Nat Genet, 43(10): 969-976. [Abstract] [Full-text]
174. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4.
     Nat Genet, 43(10): 977-83. [Abstract] [Full-text]
175. Illness management and recovery (IMR) in Danish community mental health centres.
     Trials, 12: 195. [Abstract] [Full-text]
176. High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: A four year prospective longitudinal follow-up study.
     J Psychiatr Res, 45(10): 1273-82. [Abstract] [Full-text]
177. State-dependent changes in the expression of DNA methyltransferases in mood disorder patients.
     J Psychiatr Res, 45(10): 1295-300. [Abstract] [Full-text]
178. Different neural pathways to negative affect in youth with pediatric bipolar disorder and severe mood dysregulation.
     J Psychiatr Res, 45(10): 1283-94. [Abstract] [Full-text]
179. An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.
     Eur Arch Psychiatry Clin Neurosci, 261(7): 489-508. [Abstract] [Full-text]
180. High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: a four year prospective longitudinal follow-up study.
     J Psychiatr Res, 45(10): 1273-82. [Abstract] [Full-text]
181. State-dependent changes in the expression of DNA methyltransferases in mood disorder patients.
     J Psychiatr Res, 45(10): 1295-300. [Abstract] [Full-text]
182. Different neural pathways to negative affect in youth with pediatric bipolar disorder and severe mood dysregulation.
     J Psychiatr Res, 45(10): 1283-94. [Abstract] [Full-text]
183. An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.
     Eur Arch Psychiatry Clin Neurosci, 261(7): 489-508. [Abstract] [Full-text]
184. Functional outcome in bipolar disorder: the big picture.
     Depress Res Treat, 2012: 949248. [Abstract] [Full-text]
185. Self-referential thinking, suicide, and function of the cortical midline structures and striatum in mood disorders: possible implications for treatment studies of mindfulness-based interventions for bipolar depression.
     Depress Res Treat, 2012: 246725. [Abstract] [Full-text]
186. Functional outcome in bipolar disorder: the big picture.
     Depress Res Treat, 2012: 949248. [Abstract] [Full-text]
187. Self-referential thinking, suicide, and function of the cortical midline structures and striatum in mood disorders: possible implications for treatment studies of mindfulness-based interventions for bipolar depression.
     Depress Res Treat, 2012: 246725. [Abstract] [Full-text]

© 2004-2013 Bipolar Research Today. All Rights Reserved.